U.S. PHARMACOPEIA

Search USP29  
Propoxyphene Hydrochloride
Click to View Image
C22H29NO2·HCl 375.93
Benzeneethanol, -[2-(dimethylamino)-1-methylethyl]--phenyl-, propanoate (ester), hydrochloride, [S-(R*,S*)]-.
(2S,3R)-(+)-4-(Dimethylamino)-3-methyl-1,2-diphenyl-2-butanol propionate (ester) hydrochloride [1639-60-7].
» Propoxyphene Hydrochloride contains not less than 98.0 percent and not more than 101.0 percent of C22H29NO2·HCl, calculated on the dried basis.
Packaging and storage— Preserve in tight containers.
Identification—
A: Infrared Absorption 197S
Solution: 1 in 20.
Medium: chloroform.
B: Dissolve 0.25 g of Propoxyphene Hydrochloride in 15 mL of Purified Water, and treat 3 mL of this solution with 1 mL of 6 N ammonium hydroxide to precipitate the propoxyphene base. Filter to remove the precipitate, acidify the filtrate with 2 mL of nitric acid, and add 1 mL of silver nitrate TS: a white, curdy precipitate that is soluble in an excess of 6 N ammonium hydroxide confirms the presence of silver chloride.
Melting range 741: between 163.5 and 168.5, but the range between beginning and end of melting does not exceed 3.
Specific rotation 781S: between +52 and +57.
Test solution: 10 mg per mL, in water, freshly prepared.
Loss on drying 731 Dry it at 105 for 3 hours: it loses not more than 1.0% of its weight.
Related compounds—
Mobile phase and Chromatographic system— Proceed as directed in the Assay.
Standard stock solution— Accurately weigh about 10 mg each of USP Propoxyphene Related Compound A RS and USP Propoxyphene Related Compound B RS into a 50-mL volumetric flask, dissolve using 2 mL of methanol, dilute with Mobile phase to volume, and mix.
Standard solution— Transfer 5.0 mL of the Standard stock solution to a 50-mL volumetric flask, dilute with Mobile phase to volume, and mix.
Test solution— Use the Assay preparation.
System suitability solution— Dissolve an accurately weighed quantity of USP Propoxyphene Hydrochloride RS in Standard solution, and dilute quantitatively, and stepwise if necessary, to obtain a solution having known concentrations of about 4.5 mg per mL of USP Propoxyphene Hydrochloride RS, about 0.02 mg per mL of USP Propoxyphene Related Compound A RS, and about 0.02 mg per mL of USP Propoxyphene Related Compound B RS.
Chromatographic system— Chromatograph the System suitability solution, and record the peak responses as directed for Procedure: the relative retention times are about 0.63 for propoxyphene related compound A, 0.78 for propoxyphene related compound B, and 1.0 for propoxyphene hydrochloride; the resolution, R, between propoxyphene related compound B and propoxyphene related compound A is not less than 2.0; and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure— Separately inject equal volumes (about 50 µL) of the Test solution and the Standard solution into the chromatograph, record the chromatograms, and measure the peak responses. Calculate the quantity, in mg, of propoxyphene related compound A in the portion of Propoxyphene Hydrochloride taken by the formula:
50C(rU / rS),
in which C is the concentration, in mg per mL, of USP Propoxyphene Related Compound A RS in the Standard solution; and rU and rS are the propoxyphene related compound A peak responses obtained from the Test solution and Standard solution, respectively. Not more than 0.5% of propoxyphene related compound A is found. Calculate the quantity, in mg, of propoxyphene related compound B as the hydrochloride in the portion of Propoxyphene Hydrochloride taken by the formula:
50C(361.93/325.45)(rU / rS),
in which C is the concentration, in mg per mL, of USP Propoxyphene Related Compound B RS in the Standard solution; 361.93 and 325.45 are the molecular weights of propoxyphene related compound B as the hydrochloride and propoxyphene related compound B, respectively; and rU and rS are the propoxyphene related compound B peak responses obtained from the Test solution and the Standard solution, respectively. Not more than 0.6% of propoxyphene related compound B as the hydrochloride is found.
Organic volatile impurities, Method I 467: meets the requirements.
Residual solvents 467: meets the requirements.
(Official January 1, 2007)
Assay—
0.1 M Monobasic ammonium phosphate buffer, pH 6.3— Dissolve 11.5 g of monobasic ammonium phosphate and 1.0 mL of triethylamine in 1000 mL of water, adjust with 10% sodium hydroxide to a pH of 6.3 ± 0.05, and mix.
Mobile phase— Prepare a filtered and degassed mixture of methanol and 0.1 M Monobasic ammonium phosphate buffer, pH 6.3 (67:33). Make adjustments if necessary (see System Suitability under Chromatography 621).
Standard preparation— Dissolve an accurately weighed quantity of USP Propoxyphene Hydrochloride RS in Mobile phase to obtain a solution having a known concentration of about 5.0 mg per mL.
Assay preparation— Transfer about 250 mg of Propoxyphene Hydrochloride, accurately weighed, to a 50-mL volumetric flask, dissolve in and dilute with Mobile phase to volume, and mix.
Chromatographic system (see Chromatography 621) The liquid chromatograph is equipped with a 254-nm detector and a 3.9-mm × 30-cm column that contains packing L1. The flow rate is about 1.5 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the retention time of propoxyphene hydrochloride is about 9 minutes; the tailing factor for the propoxyphene hydrochloride peak is not more than 3.5; and the relative standard deviation for replicate injections is not more than 2.0%.
Procedure— Separately inject equal volumes (about 50 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of C22H29NO2·HCl in the portion of Propoxyphene Hydrochloride taken by the formula:
50C(rU / rS),
in which C is the concentration, in mg per mL, of USP Propoxyphene Hydrochloride RS in the Standard preparation; and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Staff Liaison : Clydewyn M. Anthony, Ph.D., Scientist
Expert Committee : (MDCCA05) Monograph Development-Cough Cold and Analgesics
USP29–NF24 Page 1834
Pharmacopeial Forum : Volume No. 30(3) Page 925
Phone Number : 1-301-816-8139